Loading
A phase 3 trial in lung cancer, run by Instituto de Investigación Biomédica de Salamanca, now recruiting.
Dose-Escalation Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized Trial is a phase 3, randomised interventional study registered as NCT07015892 by Instituto de Investigación Biomédica de Salamanca, with a registry enrolment figure of 300 participants, started 2026-03-01 and due to reach its primary completion in 2028-09-01. Interventions recorded: Thoracic Radiotherapy 45 Gy BID; Thoracic Radiotherapy 60 Gy BID; Thoracic Radiotherapy SIB 45-54 Gy BID. Conditions listed: Small Cell Lung Carcinoma. Primary outcome: Progression-Free Survival (PFS). Lung eligibility wording from the registry: "* Histologically confirmed diagnosis of small cell lung cancer (SCLC)". Sites: Spain. No results are recorded here; the registry entry is the source.
Shares Limited-stage small-cell lung cancer, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Limited-stage small-cell lung cancer, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Limited-stage small-cell lung cancer, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Limited-stage small-cell lung cancer, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Limited-stage small-cell lung cancer, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.